Drug profile · INN
saxagliptin + dapagliflozin
QTERN 5/10
- Patents linked
- 0
- News articles
- 0
Quick answer
saxagliptin + dapagliflozin (QTERN 5/10) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
Key facts
Frequently asked questions
What is saxagliptin + dapagliflozin?
saxagliptin + dapagliflozin (QTERN 5/10) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
What is the brand name for saxagliptin + dapagliflozin?
QTERN 5/10 is a marketed brand name for saxagliptin + dapagliflozin. Check FDA Drugs@FDA for the current US label holder and prescribing information.